Evidence map›Paper›PMID 37463043›Full record

ArticleJMIRx med2023

The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study.

Thabo Mabuka, Natalie Naidoo, Nesisa Ncube, Thabo Yiga, Michael Ross, Kuzivakwashe Kurehwa, Mothabisi Nare Nyathi, Andrea Silaji, Tinashe Ndemera, Tlaleng Lemeke and 3 more

Open access · goldAbstract read
In one paragraph

Article in JMIRx med, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 2 countries.

Thabo MabukaThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0001-6290-525X
Natalie NaidooThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0002-8309-5433
Nesisa NcubeThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0001-5464-706X
Thabo YigaThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0003-3937-1821
Michael RossThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0001-8195-4620
Kuzivakwashe KurehwaThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0002-7005-1941
Mothabisi Nare NyathiThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0002-6172-6249
Andrea SilajiThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0002-8621-6923
Tinashe NdemeraThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0003-2001-5894
Tlaleng LemekeThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0002-2667-9838
Ridwan TaiwoThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0003-4659-0344
Willie MachariaThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0002-1811-946X
Mthokozisi SitholeThe Afrikan Research Initiative Motloung South Africa.ORCID https://orcid.org/0000-0001-6426-1291
South African Medical Research Council · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Emerging SARS-CoV-2 variants have been attributed to the occurrence of secondary, tertiary, quaternary, and quinary COVID-19 epidemic waves threatening vaccine efforts owing to their immune invasiveness. Since the importation of SARS-CoV-2 in South Africa, with the first reported COVID-19 case on March 5, 2020, South Africa has observed 5 consecutive COVID-19 epidemic waves. The evolution of SARS-CoV-2 has played a major role in the resurgence of COVID-19 epidemic waves in South Africa and across the globe. Objective: We aimed to conduct descriptive and inferential statistical analysis on South African COVID-19 epidemiological data to investigate the impact of SARS-CoV-2 lineages and COVID-19 vaccinations in South African COVID-19 epidemiology. Methods: The general methodology involved the collation and stratification, covariance, regression analysis, normalization, and comparative inferential statistical analysis through null hypothesis testing (paired 2-tailed Results: The mean daily positive COVID-19 tests in South Africa's first, second, third, fourth, and fifth COVID-19 epidemic wave periods were 11.5% (SD 8.58%), 11.5% (SD 8.45%), 13.3% (SD 9.72%), 13.1% (SD 9.91%), and 14.3% (SD 8.49%), respectively. The COVID-19 transmission rate in the first and second COVID-19 epidemic waves in South Africa was similar, while the COVID-19 transmission rate was higher in the third, fourth, and fifth COVID-19 epidemic waves than in the aforementioned waves. Most COVID-19 hospitalized cases in South Africa were in the general ward (60%-79.1%). Patients with COVID-19 on oxygen were the second-largest admission status (11.2%-16.8%), followed by patients with COVID-19 in the intensive care unit (8.07%-16.7%). Most patients hospitalized owing to COVID-19 in South Africa's first, second, third, and fourth COVID-19 epidemic waves were aged between 40 and 49 years (16.8%-20.4%) and 50 and 59 years (19.8%-25.3%). Patients admitted to the hospital owing to COVID-19 in the age groups of 0 to 19 years were relatively low (1.98%-4.59%). In general, COVID-19 hospital admissions in South Africa for the age groups between 0 and 29 years increased after each consecutive COVID-19 epidemic wave, while for age groups between 30 and 79 years, hospital admissions decreased. Most COVID-19 hospitalization deaths in South Africa in the first, second, third, fourth, and fifth COVID-19 epidemic waves were in the ages of 50 to 59 years (15.8%-24.8%), 60 to 69 years (15.9%-29.5%), and 70 to 79 years (16.6%-20.7%). Conclusions: The relaxation of COVID-19 nonpharmaceutical intervention health policies in South Africa and the evolution of SARS-CoV-2 were associated with increased COVID-19 transmission and severity in the South African population. COVID-19 vaccination in South Africa was strongly associated with a decrease in COVID-19 hospitalization and severity in South Africa.

Indexed as

COVID-19epidemiologylineagesSARS-CoV-2South Africastatisticsvaccinesvariants

Identifiers

PMID37463043
PMCPMC10337479
OpenAlexW4320513473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.